We describe these and various other statutory authorities in the relevant sections of this final rule with comment period
Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
Preclinical evidence suggests gastroprotective and anti-inflammatory properties for BPC-157 [2]
Elevated Energy Expenditure Preclinical findings demonstrate higher energy expenditure and greater fat oxidation in obese models
Individuals with certain medical conditions or those who are pregnant should avoid BPC 157
The DEFCON 1 package contains normal saline solution, electrolytes, and your choice of anti-nausea, anti-heartburn, and pain relief meds
